Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer

Gynecologic Oncology

Volumn 122, Issue 1, 2011, Pages 9-13

  Chen, Chien Chih ^a   Lin, Jin Ching ^a   Jan, Jian Sheng ^a   Ho, Shih Chu ^a   Wang, Lily ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cervical cancer; Concurrent chemotherapy; IMRT

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CANCER STAGING; CYSTITIS; DERMATITIS; DIARRHEA; DISEASE FREE SURVIVAL; DRUG DOSE COMPARISON; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; LEG EDEMA; LEUKOPENIA; LOW DRUG DOSE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; THROMBOCYTOPENIA; TREATMENT OUTCOME; URETER STRICTURE; UTERINE CERVIX CARCINOMA; VAGINA DISEASE; VAGINA NECROSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 79957757683     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.03.034     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61. (Pubitemid 29177874)
3. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43. (Pubitemid 29177872)
4. Peters WA, Liu PY, Barrett RGW. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high risk, early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a Phase III inter group study. Presented at Soc Gynecol Oncol 30th Annual Meeting, San Fransisco, CA, February 5-9; 1999.
5. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53. (Pubitemid 29177873)
6. Whitney CW, Sause W, Bundy BN, et al. Randomised comparison of fluorouracil plus cisplatin versus hydroxyurea in stage IIB/IVA in carcinoma of the cervix. J Clin Oncol 1999;17:1339-48.
7. Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach M. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2006;66:654-62. (Pubitemid 44436693)
8. Nuyttens JJ, Roberson JM, Yan D, Matinez A. The influence of small bowel motion both a conventional field and intensity modulated radiation therapy (IMRT) for rectal cancer. Cancer Radiother 2004;8:297-304. (Pubitemid 39550787)
9. Chemoradiotherapy for cervical cancer meta-analysis collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-12.
10. Chan P, Yeo I, Perkins G, Fyles A, Milosevic M. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol 2006;1:13.
11. Portelance L, Chao C, Grigsby PW, Bennet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261-6. (Pubitemid 32758886)
12. Kavanagh B, Schefter TE, Wu Q, et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002;12:260-71. (Pubitemid 34755932)
13. Esthappan J, Chaudhari C, Santanam L, et al. Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2008;72:1134-9.
14. Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000;48:1613-21.
15. Gallagher MJ, Brereton HD, Rostock RA, et al. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 1986;12:1565-73. (Pubitemid 17175240)
16. Kidd EA, Siegel BA, Dehdashti F, et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2010;77:1085-91.
17. Beriwal S, Gan GN, Heron DE, et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2007;68:166-71. (Pubitemid 46589834)
18. Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002;20:966-72. (Pubitemid 34141839)